Evidence map›Paper›PMID 20089078›Full record

ArticleClinical and experimental immunology2010

Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease.

M Fujita, E Harada, T Matsumoto, Y Mizuta, S Ikegame, H Ouchi, I Inoshima, S Yoshida, K Watanabe, Y Nakanishi

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Towards new TB vaccines.Seminars in immunopathology · 2020
    Review
  7. The Phagocyte Oxidase Controls Tolerance toJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

M FujitaResearch Institute for Diseases of the Chest, Kyushu University, Fukuoka, Japan. mfujita@fukuoka-u.ac.jp
E Harada
T Matsumoto
Y Mizuta
S Ikegame
H Ouchi
I Inoshima
S Yoshida
K Watanabe
Y Nakanishi
Fukuoka University · JPKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with chronic granulomatous disease (CGD), an inherited disorder of phagocytic cells, often contract recurrent life-threatening bacterial and fungal infections. CGD is considered to arise from a functional defect of the O(2)-generating nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in phagocytes. To determine whether or not NADPH oxidase is crucial to the host defence against Mycobacterium avium, we investigated the response against M. avium using CGD model mice (gp91-phox(-)) of C57BL/6 strain. A tracheal injection of 1 x 10(7) colony-forming units (CFU)/head of M. avium strain FN into the CGD mice resulted in a pulmonary infection, while also increasing the mortality rate. In contrast, normal C57BL/6 mice injected with same dose of the organisms did not develop severe pulmonary infection and were able to survive through 2 months of observation. The macrophages obtained from the CGD mice were observed to have a higher burden of the bacterial growth than macrophages from normal C57BL/6 mice. These results suggest that the defect of the NADPH oxidase function impairs the host defence against M. avium infection.

Indexed as

Immunity, InnateAnimalsGranulomatous Disease, ChronicHumansMacrophages, PeritonealMembrane GlycoproteinsMiceMice, KnockoutMycobacterium aviumNADPNADPH Oxidase 2NADPH OxidasesTuberculosis, PulmonaryCybb protein, mouseMembrane GlycoproteinsNADPNADPH Oxidase 2NADPH Oxidases

Identifiers

PMID20089078
PMCPMC2883117
OpenAlexW1498016890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.